Convatec Wound (2025)

16/09/2025

The product you know. Now with bold green visibility.

Your feedback was clear — you prefer the clarity of green.

We’ve updated our packaging to reflect that. Because green makes all the difference.

Same trusted product with antibiofilm MORE THAN SILVER™ Technology¹

• Backed by a wealth of clinical evidence in over 1,000 patients with proven outcomes across multiple studies, including an RCT and real-world evidence² ³ ⁴
• Supported by a wealth of lab evidence with proven in vitro results, including 29 peer-reviewed publications and posters⁵⁻⁹
• Click to learn more about the latest RCT study: https://brnw.ch/21wVNYm...
Not all claims are supported in all regulatory geographies.

References:
[1] Bowler PG, Parsons D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine. 2016;14:6–11.
[2] Dissemond J, et al. Aquacel Ag Advantage/Ag+ Extra and Cutimed Sorbact in the management of hard-to-heal wounds: a cohort study. J Wound Care. 2023;32(10):624–633.
[3] Beraldo S, et al. Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial. J Wound Care. 2025;34(3):170–178.
[4] Torkington-Stokes R, et al. Improving outcomes for patients with hard-to-heal wounds following adoption of the Wound Hygiene Protocol: real-world evidence. J Wound Care. 2024;33(5):304–310.
[5] Meredith L, et al. Assessment of Silver-Containing Gelling Fiber Dressings Against Antibiotic-Resistant Pathogens Using an in vitro Biofilm Model. Infect Drug Resist. 2023;16:7015–7019.
[6] Meredith K, et al. Assessment of the Antibiofilm Performance of Silver-Containing Wound Dressings: A Dual-Species Biofilm Model. Cureus. 2024;16(9):e70086.
[7] Suleman L, et al. Use of internally validated in vitro biofilm models to assess antibiofilm performance of silver-containing gelling fibre dressings. J Wound Care. 2020;29(3):154–161.
[8] Meredith K, et al. Poster at European Wound Management Association (EWMA) conference. Milan, Italy. 3–5 May 2023.
[9] Data on File. RPT-076322 Convatec. 2024.

AP-75729-GBL-ENG-v1

10/09/2025

The product you know. Now with bold green visibility.

Thanks to your feedback, we’ve returned to our green packaging. It’s the product you know and trust with the same powerful antibiofilm MORE THAN SILVER™ technology.¹

In the latest RCT study, management of VLUs with Aquacel® Ag+ Extra™ versus DACC dressings was associated with:²

✅ Significantly better complete wound closure rate at week 12
✅ Achieved complete wound closure 14 days faster
✅ Significantly greater percentage reduction in wound area
✅ Significantly higher rate of satisfactory clinical progress

Give your patients the chance to heal wounds faster, learn more about the latest RCT study:
https://brnw.ch/21wVD68

Not all claims are supported in all regulatory geographies.

Reference:
[1] Bowler PG, Parsons, D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine 14 (2016) 6–11.
[2] Beraldo S, et al. Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial. J Wound Care. 2025;34(3):170–178

AP-75729-GBL-ENG-v1

09/09/2025

What does better healing really look like in practice? 🩹

A recent randomised controlled trial (RCT) compared CISEB vs DACC dressings in patients with venous leg ulcers, evaluating the effectiveness of an enhanced silver-containing dressing in healing outcomes.¹

For healthcare professionals, this trial highlights the impact that dressing choice can have on wound closure rates.¹

In an environment where every clinical decision matters, high-quality evidence like this is vital for guiding best practice.

Explore the key findings in the video below. 📺

Reference:
1. Beraldo S. et al. Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial. Journal of Wound Care, 2025.

02/09/2025

New NICE guidance on topical antimicrobial dressings. What does this mean for clinical practice? 🧑‍⚕️

The latest evaluation from NICE - National Institute for Health and Care Excellence provides important clarity on the use of topical antimicrobial dressings for locally infected leg ulcers, a topic of growing clinical relevance.¹ ² ³

That’s where recent research, such as the randomised controlled trial by Beraldo et al., plays a critical role.¹

This study demonstrated a statistically significant improvement in complete healing rates for a specific antimicrobial dressing containing silver agents, underscoring the value of rapid progression to wound closure.¹

For HCPs working under pressure, this is more than a guideline update. It’s a chance to re-evaluate dressing choices through the lens of both healing outcomes and health economics.

Explore the key findings in the video below. 📺

References:
1. Beraldo et al. J Wound Care. 2025;35(3):170-178.
2. Holmes et al. [GID-HTE10041] - Topical Antimicrobial Dressings for Infected Leg Ulcers in People and 16 and over. Second Addendum.; NICE, York Health Economic Consortium. 2025.
3. Holmes et al. [GID-HTE10041] - Topical Antimicrobial Dressings for Infected Leg Ulcers in People and 16 and over. External Assessment Group Report.; NICE, York Health Economic Consortium. 2025.

28/08/2025

Say NO to biofilm! 🙅

Diabetes is the disease that contributes to the greatest number of diagnosed chronic wounds¹, and biofilms are one of the main reason why diabetic foot ulcers (DFUs) fail to heal.²

ConvaNiox™ is a multimodal wound dressing that creates an optimised wound healing environment to increase the probability of healing of diabetic foot ulcers (DFUs) by combining an advanced dressing technology with a potent antimicrobial and antibiofilm* agent, nitric oxide (NO).³

ConvaNiox™ has demonstrated robust clinical results, reducing the wound area three times faster and increasing DFU healing by 60%, compared to the standard of care, in a randomised controlled trial.⁴ ⁵

*Not all claims are supported in every market

Learn more: 🔗

https://brnw.ch/21wVgra

References:

1. Malone-Povolny. M J. et al., “Nitric Oxide Therapy for Diabetic Wound Healing,” Adv Healthc Mater, vol. 8, no. 12, 15 January, 2025, e1801210, , accessed 16 July, 2025.

2. Afonso, A C. et al., “Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies,” Int J Mol Sci, vol. 22, no. 15, 31 July, 2021, 8278, , accessed 16 July, 2025.

3. RPT-088112 DHF 1161_ConvaNiox Claims summary, Data on file, Convatec.

4. Edmonds. ME. et al., "Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study," Wound Repair Regeneration, vol. 26, no. 2, 04 April 2018, pp. 228-237, , accessed 16 July, 2025.

5. McDermott. K. et al., “Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers,” Diabetes Care, vol. 46, no. 1, 2 January, 2023, pp. 209-221, , accessed 16 July, 2025.

27/08/2025

When it makes such a difference, you need to see a clearer difference.

Thanks to your feedback, we’ve returned to our green packaging. It’s the product you know and trust, now with bold green visibility and the same powerful antibiofilm MORE THAN SILVER™ technology.¹

Now it’s easier for you to pick out in a busy clinical environment, when clarity is of the utmost importance.

If you want to improve your patients’ quality of life, pick out the green one: https://brnw.ch/21wVfeg

Not all claims are supported in all regulatory geographies.

References:

[1] Bowler PG, Parsons, D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine 14 (2016) 6–11.

AP-75367-GBL-ENG-v1

25/08/2025

Better, faster, safer. Aquacel® Ag+ Extra™.¹ 🔍

In a recent randomised controlled trial, it was revealed that Aquacel® Ag+ Extra™ drives a higher probability of closure and fewer dressing-related complications than Cutimed® Sorbact®.¹

The data also demonstrated faster healing and a lower adverse-event burden.¹

Discover the headline findings of the trial below. 📽️

References:

1. Beraldo. S. et al., "Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial," Journal of Wound Care, vol. 34, no. 3, 24 February, 2025, pp. 170 - 178, , accessed 30 July, 2025.

21/08/2025

What is the NICE HTE27 guidance and why does it matter? 🤔

LSA guidance evaluates dressings on three fronts: clinical efficacy, cost-effectiveness and environmental considerations.¹

Aquacel® Ag+ Extra™ combines two powerful technologies: MORE THAN SILVER™ technology that disrupts biofilm and Hydrofiber® Technology which helps manage exudate.²

Swipe below for the headlines from this evaluation. ⤵️

References:

1. National Institute for Health and Care Excellence, “Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment,” HTE27, 19 June, 2025, , accessed 16 Jul, 2025.

2. Bowler PG, Parsons, D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine 14 (2016) 6–11

20/08/2025

Be Sure in 4 with the Wound Hygiene Pathway.¹ 4️⃣

Biofilm is a major barrier to healing: it's present in nearly 8 out of 10 hard-to-heal wounds² and delays wound healing.³

The Convatec four-step Wound Hygiene Pathway improves healing rates and lowers infection risk.¹

Swipe below to discover the steps. 📲

References:

1. Murphy C, Atkin L, Swanson T, Tachi M, Tan YK, Vega de Ceniga M, Weir D, Wolcott R. International consensus document. Defying hard-to-heal wounds with an early antibiofilm intervention strategy: Wound Hygiene. J Wound Care 2020; 29(Suppl 3b):S1–28

2. Malone. M. et al., “The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data,” Journal of Wound Care, vol. 26, no. 1, 19 January, 2017, pp. 20-25, , accessed 16 July, 2025.

3. Metcalf. D G. et al., “Biofilm delays wound healing: A review of the evidence,” Burns & Trauma, vol. 1, no. 1, 18 June, 2013, pp. 5-12, , accessed 16 July, 2025.

19/08/2025

Five weeks to heal then back to the pool with the Convatec Wound Hygiene Pathway and Aquacel® Extra™. 🏊‍♀️

After her last surgery, Anne expected she would have to wait 8 months for her wound to heal when she had to have another procedure²

That was until nurse Jay combined the Convatec Wound Hygiene Pathway³ with Aquacel® Extra™ Dressing.¹ The wound closed in just five weeks, not eight months.²

‘It healed the wound so much faster… I was back swimming in five or six weeks.²

Here's Jay and Anne to tell their story. 📺

References:
1. Convatec, “Aquacel® Extra™ Dressing,” 2025, , accessed 16 July, 2025.

2. Data on file, “Jay & Anne Case Study,” AP-74454-GBL-ENG-v1, Convatec, 2024.

3. Convatec, “Wound Hygiene,” 2025, , accessed 16 July, 2025.

31/07/2025

Designed with high tensile strength to be removed in one-piece easily²⁵ and eliminating pain at dressing change²⁴, Aquacel® Extra™ can be cut in any direction without compromising its integrity.²⁶
*Machine direction

Aquacel® Extra™ has superior wet tensile strength to other* than other fibre dressings such as Biatain® Fiber, Exufiber® and alginate dressings (Askina® Sorb and Algosteril®).²⁷
*Machine direction

In clinical practice, alginate dressings were difficult to remove due to dressings breaking up or being mistaken for devitalised tissue and being left in the wound.²⁵

References:
24. Barnea Y, Amir A, Lesham D et al. (2004) ‘Clinical comparative study of Aquacel® and paraffin gauze dressing for split-skin donor site treatment’, Ann Plast Surg,132-113
25. Leek K. (2022) Exploring the differences between alginate & gelling fibre dressings for managing exudate and improving clinical outcomes. Wound Care Today Conference poster.
26. Aquacel Extra™ Instruction For Use 1738657V1.
27. AWC-2022-005 ver 3.0 Convatec (2022) Data on file

29/07/2025

In this video, Prof. Dr. med. Joachim Dissemond, Dermatologist, University Hospital Essen, Germany, discusses the results found in our latest randomised clinical trial (RCT) on Aquacel® Ag+ Extra™ vs DACC antimicrobial dressings.

Download the summary or find out more here: https://brnw.ch/21wUuYX

Convatec Wound